Bcl9l - B cell CLL/lymphoma 9-like Gene
Also Known as B9L; BCL9-2; DLNB11
Species: Mus musculus
Gene Type: protein coding
Gene ID: 80288
Summary
Enables beta-catenin binding activity. Acts upstream of or within several processes, including canonical Wnt signaling pathway; skeletal muscle cell differentiation; and somatic stem cell population maintenance. Located in nucleus. Is expressed in several structures, including respiratory system cartilage; sensory organ; skeleton; trunk unsegmented mesenchyme; and vibrissa. Orthologous to human BCL9L (BCL9 like). [provided by Alliance of Genome Resources, Apr 2022]
Bcl9l Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_001357490.1 | NP_001344419.1 | B-cell CLL/lymphoma 9-like protein isoform 2 |
| NM_030256.3 | NP_084532.2 | B-cell CLL/lymphoma 9-like protein isoform 1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
B-cell CLL/lymphoma 9-like protein |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS01444 | BCL9L Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS21497 | Bcl9l Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS28015 | Bcl9l Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service